In conclusion, by focusing on the major components of obesity pathophysiology we created a novel fusion protein named EAT for pharmacological intervention of obesity and its associated metabolic disorders. This evidence concerns the gene MCL1 and obesity due to melanocortin 4 receptor deficiency.